New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Blocking proteins could pull the plug on power for colon tumors

Blocking proteins could pull the plug on power for colon tumors

by Virginia Commonwealth UniversityCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113081Throughstudy findingspublished inCell Reports, a team of scientists at
Oncology April 01,2024
Blocking proteins could pull the plug on power for colon tumors

Blocking proteins could pull the plug on power for colon tumors

by Virginia Commonwealth UniversityCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113081Throughstudy findingspublished inCell Reports, a team of scientists at
Oncology April 01,2024
Stopping cancer from recruiting immune system double agents

Stopping cancer from recruiting immune system double agents

by Rush University Medical CenterCredit: Rush University Medical CenterCancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the
Oncology April 01,2024
Stopping cancer from recruiting immune system double agents

Stopping cancer from recruiting immune system double agents

by Rush University Medical CenterCredit: Rush University Medical CenterCancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the
Oncology April 01,2024
T-cell interactions vary between tumor microenvironments

T-cell interactions vary between tumor microenvironments

by Melissa Rohman,Northwestern UniversityShown is a p-STAT3- non-reactive astrocyte (white arrow) in close proximity to a CD3+p-STAT3- T cell (blue arrow) and a CD163+p-STAT3- macrophage (red ar
Oncology April 01,2024
T-cell interactions vary between tumor microenvironments

T-cell interactions vary between tumor microenvironments

by Melissa Rohman,Northwestern UniversityShown is a p-STAT3- non-reactive astrocyte (white arrow) in close proximity to a CD3+p-STAT3- T cell (blue arrow) and a CD163+p-STAT3- macrophage (red ar
Oncology April 01,2024
Breast cancer recurrence rate not up with autologous fat transfer

Breast cancer recurrence rate not up with autologous fat transfer

(HealthDay)—For patients with breast cancer, reconstruction with autologous fat transfer (AFT) seems not to increase the rate of locoregional recurrence versus conventional breast reconstruction, acco
Oncology April 01,2024
Breast cancer recurrence rate not up with autologous fat transfer

Breast cancer recurrence rate not up with autologous fat transfer

(HealthDay)—For patients with breast cancer, reconstruction with autologous fat transfer (AFT) seems not to increase the rate of locoregional recurrence versus conventional breast reconstruction, acco
Oncology April 01,2024
Presidential panel says high-priced cancer drugs harm patient care

Presidential panel says high-priced cancer drugs harm patient care

by Dennis Thompson, Healthday Reporter(HealthDay)—"Financial toxicity" caused by high cancer drug prices is harming people's ability to fight the dreaded disease, a new report from the P
Oncology April 01,2024
Presidential panel says high-priced cancer drugs harm patient care

Presidential panel says high-priced cancer drugs harm patient care

by Dennis Thompson, Healthday Reporter(HealthDay)—"Financial toxicity" caused by high cancer drug prices is harming people's ability to fight the dreaded disease, a new report from the P
Oncology April 01,2024
Clinical presentation of IDDMSSD syndrome likely associated with molecular location of mutation in PAK1 gene

Clinical presentation of IDDMSSD syndrome likely associated with molecular location of mutation in PAK1 gene

by Texas Children's HospitalCredit: Pixabay/CC0 Public DomainA recent study from Texas Children's Hospital and Baylor College of Medicine has expanded the clinical spectrum of a new epileptic
Breakthroughs April 01,2024
Clinical presentation of IDDMSSD syndrome likely associated with molecular location of mutation in PAK1 gene

Clinical presentation of IDDMSSD syndrome likely associated with molecular location of mutation in PAK1 gene

by Texas Children's HospitalCredit: Pixabay/CC0 Public DomainA recent study from Texas Children's Hospital and Baylor College of Medicine has expanded the clinical spectrum of a new epileptic
Breakthroughs April 01,2024
Blocking a protein to prevent injuries caused by radiation therapy

Blocking a protein to prevent injuries caused by radiation therapy

by Umea UniversityMahsa Fallah in lab. Credit: Johan GunséusIt is possible to prevent certain injuries that can occur in radiation therapy against cancer. By blocking the activity of a plasma pro
Oncology April 01,2024
Blocking a protein to prevent injuries caused by radiation therapy

Blocking a protein to prevent injuries caused by radiation therapy

by Umea UniversityMahsa Fallah in lab. Credit: Johan GunséusIt is possible to prevent certain injuries that can occur in radiation therapy against cancer. By blocking the activity of a plasma pro
Oncology April 01,2024
Stopping the resistance of cancer cells to treatment

Stopping the resistance of cancer cells to treatment

by Colin Poitras,University of ConnecticutCredit: CC0 Public DomainOne of the drawbacks of chemotherapy is that cancer patients can build up resistance to treatment over time, increasing their c
Oncology April 01,2024
Stopping the resistance of cancer cells to treatment

Stopping the resistance of cancer cells to treatment

by Colin Poitras,University of ConnecticutCredit: CC0 Public DomainOne of the drawbacks of chemotherapy is that cancer patients can build up resistance to treatment over time, increasing their c
Oncology April 01,2024
Overall, drinking wine does not impact prostate cancer risk

Overall, drinking wine does not impact prostate cancer risk

(HealthDay)—Moderate wine consumption does not seem to impact the risk of prostate cancer, according to a review published online April 17 inClinical Epidemiology.Mihai Dorin Vartolomei, Ph.D.,
Oncology April 01,2024
Overall, drinking wine does not impact prostate cancer risk

Overall, drinking wine does not impact prostate cancer risk

(HealthDay)—Moderate wine consumption does not seem to impact the risk of prostate cancer, according to a review published online April 17 inClinical Epidemiology.Mihai Dorin Vartolomei, Ph.D.,
Oncology April 01,2024
Accurately diagnosing genetic disease prevents cancer, saves lives

Accurately diagnosing genetic disease prevents cancer, saves lives

by The Ohio State University Comprehensive Cancer CenterCredit: CC0 Public DomainA single, upfront genomic test is more effective for detecting Lynch syndrome in colorectal cancer (CRC) patients than
Oncology April 01,2024
Accurately diagnosing genetic disease prevents cancer, saves lives

Accurately diagnosing genetic disease prevents cancer, saves lives

by The Ohio State University Comprehensive Cancer CenterCredit: CC0 Public DomainA single, upfront genomic test is more effective for detecting Lynch syndrome in colorectal cancer (CRC) patients than
Oncology April 01,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com